Rocky Mountain Cancer Centers Revenue and Competitors

Cherry Creek, CO USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Rocky Mountain Cancer Centers's estimated annual revenue is currently $193.7M per year.(i)
  • Rocky Mountain Cancer Centers's estimated revenue per employee is $337,500

Employee Data

  • Rocky Mountain Cancer Centers has 574 Employees.(i)
  • Rocky Mountain Cancer Centers grew their employee count by 4% last year.

Rocky Mountain Cancer Centers's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$359.5M95111%N/AN/A
#2
$12.6M5221%N/AN/A
#3
$7.8M360%N/AN/A
#4
$106.3M3155%N/AN/A
#5
$137M40617%N/AN/A
#6
$1881.3M49771105%N/AN/A
#7
$6.9M323%N/AN/A
#8
$6.9M323%N/AN/A
#9
$7.8M360%N/AN/A
#10
$14.1M589%N/AN/A
Add Company

What Is Rocky Mountain Cancer Centers?

Learn about working at Rocky Mountain Cancer Centers. Join LinkedIn today for free. See who you know at Rocky Mountain Cancer Centers, leverage your professional network, and get hired.

keywords:N/A

N/A

Total Funding

574

Number of Employees

$193.7M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Rocky Mountain Cancer Centers News

2022-04-20 - 6 Covid mysteries experts hope to unravel - STAT

There may still come a time (or times) when the Centers for Disease ... of Allergy and Infectious Diseases' Rocky Mountain Laboratories.

2022-04-17 - The Big Payout: Colorado health care providers used COVID aid as lifelines to stay afloat

Radiation Therapist Kristen Sherry-Taylor prepares a medical linear accelerator for a patient at Rocky Mountain Cancer Centers in Aurora,...

2022-04-17 - Conference Coverage: Community Oncology Alliance 2022

... executive director of Rocky Mountain Cancer Centers; Jeff Vacirca, MD, CEO of New York Cancer & Blood Specialists; and Emily Touloukian,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$144.1M73524%N/A
#2
$356.7M7727%N/A
#3
$149.4M889-2%N/A
#4
$416.2M11017%N/A
#5
$429.1M11491%N/A